Clinical Biology and Surgical Therapy of Intramucosal Adenocarcinoma of the Esophagus

Journal of the American College of Surgeons

Volumn 203, Issue 2, 2006, Pages 152-161

  Oh, Daniel S ^a   Hagen, Jeffrey A ^a   Chandrasoma, Parakrama T ^a   Dunst, Christy M ^a   DeMeester, Steven R ^a   Alavi, Mohammad ^a   Bremner, Cedric G ^a   Lipham, John ^a   Rizzetto, Christian ^a   Cote, Richard ^a   DeMeester, Tom R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS MUCOSA; ESOPHAGUS RESECTION; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR LOCALIZATION;

ADENOCARCINOMA; AGED; BIOPSY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOSCOPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; KERATINS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 33746057823     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2006.05.006     Document Type: Article

References (44)

1. Conio M., Cameron A.J., Romero Y., et al. Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota. Gut 48 (2001) 304-309
2. Blot W.J., and McLaughlin J.K. The changing epidemiology of esophageal cancer. Semin Oncol 26 Suppl 15 (1999) 2-8
3. Mino-Kenudson M., Brugge W.R., Puricelli W.P., et al. Management of superficial Barrett's epithelium-related neoplasms by endoscopic mucosal resection. clinicopathologic analysis of 27 cases. Am J Surg Pathol 29 (2005) 680-686
4. Ell C., May A., Gossner L., et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 118 (2000) 670-677
5. May A., Gossner L., Pech O., et al. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus. acute-phase and intermediate results of a new treatment approach. [see comment]. Eur J Gastroenterol Hepatol 14 (2002) 1085-1091
6. Peters F.P., Kara M.A., Rosmolen W.D., et al. Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett's esophagus. Gastrointest Endosc 61 (2005) 506-514
7. Overholt B.F., Panjehpour M., and Haydek J.M. Photodynamic therapy for Barrett's esophagus. follow-up in 100 patients. [see comment]. Gastrointest Endosc 49 (1999) 1-7
8. Overholt B.F., Panjehpour M., and Halberg D.L. Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma. long-term results. [see comment]. Gastrointest Endosc 58 (2003) 183-188
9. Pacifico R.J., Wang K.K., Wongkeesong L.M., et al. Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus. [see comment]. Clin Gastroenterol Hepatol 1 (2003) 252-257
10. Akiyama H., Tsurumaru M., Ono Y., et al. Esophagectomy without thoracotomy with vagal preservation. J Am Coll Surg 178 (1994) 83-85
11. Shi S.R., Cote R.J., and Taylor C.R. Antigen retrieval immunohistochemistry. past, present, and future. J Histochem Cytochem 45 (1997) 327-343
12. Oberg S., DeMeester T.R., Peters J.H., et al. The extent of Barrett's esophagus depends on the status of the lower esophageal sphincter and the degree of esophageal acid exposure. J Thorac Cardiovasc Surg 117 (1999) 572-580
13. Csendes A., Smok G., Quiroz J., et al. Clinical, endoscopic, and functional studies in 408 patients with Barrett's esophagus, compared to 174 cases of intestinal metaplasia of the cardia. Am J Gastroenterol 97 (2002) 554-560
14. DeMeester S.R., Wickramasinghe K.S., Lord R.V.N., et al. Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus. [see comment]. Am J Gastroenterol 97 (2002) 2514-2523
15. Balaji N.S., DeMeester S.R., Wickramasinghe K.S., et al. Etiology of intestinal metaplasia at the gastroesophageal junction. Surg Endosc 17 (2003) 43-48
16. Clark G.W., Smyrk T.C., Burdiles P., et al. Is Barrett's metaplasia the source of adenocarcinomas of the cardia?. Arch Surg 129 (1994) 609-614
17. Kubo A., and Corley D.A. Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States. Am J Gastroenterol 99 (2004) 582-588
18. Sharma P., and Sidorenko E.I. Are screening and surveillance for Barrett's oesophagus really worthwhile?. Gut 54 Suppl 1 (2005) i27-i32
19. Sharma P., McQuaid K., Dent J., et al. A critical review of the diagnosis and management of Barrett's esophagus. the AGA Chicago Workshop. Gastroenterology 127 (2004) 310-330
20. Inadomi J.M., Sampliner R., Lagergren J., et al. Screening and surveillance for Barrett esophagus in high-risk groups. a cost-utility analysis. [see comment]. Ann Intern Med 138 (2003) 176-186
21. Streitz Jr. J.M., Ellis Jr. F.H., Tilden R.L., et al. Endoscopic surveillance of Barrett's esophagus. a cost-effectiveness comparison with mammographic surveillance for breast cancer. Am J Gastroenterol 93 (1998) 911-915
22. Harewood G.C. Economic comparison of current endoscopic practices. Barrett's surveillance vs. ulcerative colitis surveillance vs. biopsy for sprue vs. biopsy for microscopic colitis. Dig Dis Sci 49 (2004) 1808-1814
23. Peters J.H., Clark G.W., Ireland A.P., et al. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg 108 (1994) 813-821 discussion 821-822
24. Fountoulakis A., Zafirellis K.D., Dolan K., et al. Effect of surveillance of Barrett's oesophagus on the clinical outcome of oesophageal cancer. Br J Surg 91 (2004) 997-1003
25. Streitz Jr. J.M., Andrews Jr. C.W., and Ellis Jr. F.H. Endoscopic surveillance of Barrett's esophagus. Does it help?. J Thorac Cardiovasc Surg 105 (1993) 383-387 discussion 387-388
26. Reid B.J., Levine D.S., Longton G., et al. Predictors of progression to cancer in Barrett's esophagus. baseline histology and flow cytometry identify low- and high-risk patient subsets. Am J Gastroenterol 95 (2000) 1669-1676
27. Sontag S., Schnell T., Chejfec G., et al. Barrett's low grade dysplasia (LGD) and fear; yearly endoscopy (EGD) is not justified. surveillance every 2-3 years detects all cancers early. Gastroenterology 116 Suppl (1999) A316
28. Hameeteman W., Tytgat G.N., Houthoff H.J., and van den Tweel J.G. Barrett's esophagus. development of dysplasia and adenocarcinoma. [see comment]. Gastroenterology 96 (1989) 1249-1256
29. Oberg S., Wenner J., Johansson J., et al. Barrett esophagus. risk factors for progression to dysplasia and adenocarcinoma. Ann Surg 242 (2005) 49-54
30. Theisen J., Nigro J.J., DeMeester T.R., et al. Chronology of the Barrett's metaplasia-dysplasia-carcinoma sequence. Dis Esophagus 17 (2004) 67-70
31. Gurski R.R., Peters J.H., Hagen J.A., et al. Barrett's esophagus can and does regress after antireflux surgery. a study of prevalence and predictive features. [see comment]. J Am Coll Surg 196 (2003) 706-712 discussion 712-713
32. May A., Gunter E., Roth F., et al. Accuracy of staging in early oesophageal cancer using high resolution endoscopy and high resolution endosonography. a comparative, prospective, and blinded trial. Gut 53 (2004) 634-640
33. Larghi A., Lightdale C.J., Memeo L., et al. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus. Gastrointest Endosc 62 (2005) 16-23
34. Maish M.S., and DeMeester S.R. Endoscopic mucosal resection as a staging technique to determine the depth of invasion of esophageal adenocarcinoma. Ann Thorac Surg 78 (2004) 1777-1782
35. Chandrasoma P.T., Der R., Dalton P., et al. Distribution and significance of epithelial types in columnar-lined esophagus. Am J Surg Pathol 25 (2001) 1188-1193
36. Theodorou D., Streets C., Chandrasoma P., et al. Comparison of the pH and intestinal metaplasia density across long segment Barrett's esophagus. Gastroenterology 122 (2002) A51
37. Rice T.W., Blackstone E.H., Goldblum J.R., et al. Superficial adenocarcinoma of the esophagus. [see comment]. J Thorac Cardiovasc Surg 122 (2001) 1077-1090
38. Liu L., Hofstetter W.L., Rashid A., et al. Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma. Am J Surg Pathol 29 (2005) 1079-1085
39. Stein H., Feith M., Bruecher B., et al. Early esophageal cancer. pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg 242 (2005) 566-575
40. Westerterp M., Koppert L.B., Buskens C.J., et al. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastroesophageal junction. Virchows Arch 446 (2005) 497-504
41. Waterman T.A., Hagen J.A., Peters J.H., et al. The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma. Ann Thorac Surg 78 (2004) 1161-1169 discussion 1169
42. O'Sullivan G.C., Collins J.K., Kelly J., et al. Micrometastases. marker of metastatic potential or evidence of residual disease. [see comment]. Gut 40 (1997) 512-515
43. Nigro J.J., Hagen J.A., DeMeester T.R., et al. Occult esophageal adenocarcinoma. extent of disease and implications for effective therapy. Ann Surg 230 (1999) 433-438 discussion 438-440
44. Banki F., Mason R.J., DeMeester S.R., et al. Vagal-sparing esophagectomy. a more physiologic alternative. Ann Surg 236 (2002) 324-335 discussion 335-336